): Candidate: This is the candidate's first faculty position as Assistant Professor in General Internal Medicine at the Univ. of Texas at Houston. During her fellowship at the Center for Clinical Bioethics at Georgetown Univ. she completed work in biostatistics, epidemiology, moral philosophy and public health, and research that won the National Research Service Award from the Agency for Health Care Policy and Research and Health Resources and Services Administration. She gave oral presentations at the regional and national meetings of the Society of General Internal Medicine. An abstract of her work has been published in a peer-reviewed journal and the manuscript is currently under review for publication. She has recently been appointed to the State Prostate Cancer Advisory Committee (SPCAC) to the Texas Dept. of Health. Research: This K08 proposal builds upon the candidate's fellowship work about informed consent for prostate cancer screening with the prostate specific antigen (PSA) test and is a collaborative project with the SPCAC. Screening for prostate cancer with PSA is controversial because it is not clear whether it is an effective mass screening test. Until clinical trials resolve this issue, informed consent for PSA screening is recommended. Using a proposed standard of informed consent for PSA screening derived from her fellowship study, the candidate will study the content of informed consent in clinical practice. To determine which facts about PSA screening different health care providers consider important to disclose, she will conduct a nationwide survey of primary care providers. To determine which facts about PSA screening men in different health care settings know, she will survey men seeking care in managed care, university and private practices. Working with SPCAC, she will run focus groups to develop and pilot test a brochure with facts about PSA screening so that the Texas Dept. of Health can distribute it to the public during Prostate Awareness Week. This plan can be a potential role model for evaluating the content of informed consent for genetic screening tests for hereditary forms of breast cancer and colorectal cancer. This proposal will also give her the quantitative research skills needed to become a leading independent clinical investigator in the fields of biomedical ethics and cancer screening. Environment: The Texas medical Center, UT-School of Public Health and M.D. Anderson Cancer Center offer nationally known resources to meet the multidisciplinary needs of the candidate.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08CA078615-03
Application #
6173903
Study Section
Subcommittee G - Education (NCI)
Program Officer
Myrick, Dorkina C
Project Start
1998-09-11
Project End
2002-08-31
Budget Start
2000-09-01
Budget End
2002-08-31
Support Year
3
Fiscal Year
2000
Total Cost
$86,724
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771594
City
Houston
State
TX
Country
United States
Zip Code
77225
Chan, Evelyn C Y; Barry, Michael J; Vernon, Sally W et al. (2006) Brief report: physicians and their personal prostate cancer-screening practices with prostate-specific antigen. A national survey. J Gen Intern Med 21:257-9
Chan, Evelyn C Y; Vernon, Sally W; Ahn, Chul et al. (2004) Do men know that they have had a prostate-specific antigen test? Accuracy of self-reports of testing at 2 sites. Am J Public Health 94:1336-8
Chan, Evelyn C Y; Haynes, Michelle C; O'Donnell, Frederick T et al. (2003) Cultural sensitivity and informed decision making about prostate cancer screening. J Community Health 28:393-405
Chan, Evelyn C Y; Vernon, Sally W; Haynes, Michelle C et al. (2003) Physician perspectives on the importance of facts men ought to know about prostate-specific antigen testing. J Gen Intern Med 18:350-6
Chan, Evelyn C Y; Vernon, Sally W; O'Donnell, Frederick T et al. (2003) Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message? Am J Public Health 93:779-85